Chargement en cours...
Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high human immunodeficiency virus and tuberculosis burden countries: A systematic review
AIMS: Efavirenz (EFV) and rifampicin–isoniazid (RH) are cornerstone drugs in human immunodeficiency virus (HIV)–tuberculosis (TB) coinfection treatment but with complex drug interactions, efficacy and safety challenges. We reviewed recent data on EFV and RH interaction in TB/HIV high‐burden countrie...
Enregistré dans:
| Publié dans: | Br J Clin Pharmacol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6046471/ https://ncbi.nlm.nih.gov/pubmed/29624706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13600 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|